Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 12/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 10/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6060195 | 1.00 | MIF (0.44) | MIFESR1KDM4EALDH1A1GAA | |
| SCHEMBL2437641 | 0.84 | KDM4E (0.44) | MIFESR1KDM4EALDH1A1GAA | |
| SCHEMBL2437638 | 0.84 | KDM4E (0.44) | MIFESR1KDM4EALDH1A1GAA | |
| SCHEMBL2432259 | 0.80 | KDM4E (0.43) | KDM4EALDH1A1ATG4BPLA2G1BTHRA | |
| SCHEMBL2432260 | 0.80 | KDM4E (0.43) | KDM4EALDH1A1ATG4BPLA2G1BTHRA | |
| SCHEMBL8055896 | 0.77 | MIF (0.53) | MIFESR1KDM4EALDH1A1THRB | |
| SCHEMBL8055895 | 0.77 | MIF (0.53) | MIFESR1KDM4EALDH1A1THRB | |
| SCHEMBL1319856 | 0.75 | IAPP (0.43) | ESR1KDM4EATG4BPLA2G1BTHRA | |
| SCHEMBL2931781 | 0.75 | ESR1 (0.47) | ESR1KDM4EALDH1A1GAATHRB | |
| SCHEMBL2429698 | 0.75 | KDM4E (0.46) | MIFKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1735262-A1 | PROCESS FOR PREPARING CINNAMIC ACIDS AND ALKYL ESTERS THEREOF | Honeywell International, Inc. (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005105728-A1 | PROCESS FOR PREPARING CINNAMIC ACIDS AND ALKYL ESTERS THEREOF | HONEYWELL INTERNATIONAL INC. (US) | 2005-11-10 | — | — | WO | disclosed |
| US-20050234261-A1 | Process for preparing cinnamic acids and alkyl esters thereof | HONEYWELL INTERNATIONAL INC. | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234261-A1 | Process for preparing cinnamic acids and alkyl esters thereof | PCCA, LIPA, CA7 | MIF 3045/4885ESR1 1358/4885KDM4E 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.